Abstract
In 1997, 30% of total health care expenditures ($326.6 billion) in the United States were directly or indirectly related to cardiovascular disease (CVD) (1). Given the enormous financial burden placed on society by CVD, there is an increasing interest in evaluating the efficiency with which the dollars are spent. Cost-effectiveness analysis (CEA) is a methodology designed for such evaluations.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gaziano J. Global burden of cardiovascular disease. In: Braunwald E, Zipes DP, Libby P (eds.). Heart Disease: A Textbook of Cardiovascular Medicine, 6th Edition. WB Saunders Publishing: 2001, pp. 1–17.
Weinstein M, Siegel J, Gold M, et al. for the Panel on Cost effectiveness in health and medicine. Recommendations of the Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996; 276: 1253–1258.
Siegel J, Weinstein M, Russell L, Gold M for the Panel on Cost Effectiveness in Health and Medicine. Recommendations for reporting cost-effectiveness analyses. JAMA 1996; 276: 1339–1341.
Gafni G, Birch S. Equity considerations in utility-based measures of health outcomes in economic appraisals: an adjustment algorithm. J Health Econ 1991; 10: 329–342.
Schulpher M, Gafni A. Recognizing diversity in public preferences: the use of preference sub-groups in cost-effectiveness analysis. Health Econ 2001; 10: 317–324.
Gold M, Siegel J, Russell L, Weinstein M (eds.). Cost Effectiveness in Health and Medicine. Oxford Press, New York: 1996.
Suwaidi J, Berger P, Holmes D. Coronary artery stents. JAMA 2000; 284: 1828–1836.
Peterson ED, Lansky Ai, Kramer J, et al. National Cardiovascular Network Clinical Investigators. Effect of gender on the outcomes of contemporary percutaneous coronary intervention. Am J Cardiol 2001; 88: 359–364.
Peterson E, Cowper P, DeLong E, et al. Acute and long-term cost implications of coronary stenting. Interven Cardiol 1999; 33: 1610–1618.
Edwards F, Carey J, Grover F, et al. Impact of gender on coronary bypass operative mortality. Ann Thor Surg 1998; 66: 125–131.
Mehilli J, Kastrati A, Dirschinger J, et al. Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting. JAMA 2000; 284: 1799–1804.
Afonso F, Hernandez R, Banuelos C, et al. Initial results and long-term clinical and angiographie outcome of coronary stenting in women. Am J Cardiol 2000; 86: 1380–1383.
Robertson T, Kennard E, Mehta S, et al. Influence of gender on in-hospital clinical and angiographie outcomes and on one-year follow-up in the new approaches to coronary intervention (NACI) registry.“ Am J Cardiol 1997; 80: 26K - 39K.
Malenka D, O’Connor G, Quinton H, et al. Differences in outcomes between women and men associated with percutaneous transluminal coronary angioplasty. Circulation 1996;94:II-99-II-103.
Arnold A, Mick M, Piedmonte M, Simpfendorfer C. Gender differences for coronary angioplasty. Am J Cardiol 1994; 74: 18–21.
Antoniucci D, Valenti R, Moschi G, et al. Sex-based differences in clinical and angiographie outcomes after primary angioplasty or stenting for acute myocardial infarction. Am J Cardiol 2001; 87: 289–293.
Cohen D, Krumholz H, Sukin C, et al. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty: results from a randomized clinical trial.“ Circulation 1995; 92: 2480–2487.
Weintraub W, Becker E, Mauldin P, et al. “Costs of revascularization over eight years in the randomized and eligible patients in the emory angioplasty versus surgery trial (EAST)”. Am J Cardiol 2000; 86: 747–752.
Lecomte P, McKenna M, Kennedy L, et al. International review of the utilisation and cost of percutaneious transluminal coronary angioplasty. Health Econ Preven Care 2001; 2: 118–127.
Cohen D. “Evaluation of the cost-effectiveness of coronary stenting: A societal prespective.” Am Heart J 1999; 137 (5 Suppl): S133–5137.
Murray C, Evans D, Acharya A, Baltussen R. “Development of WHO guidelines on generalized cost-effectiveness analysis.” Health Econ 2000; 9: 235–251.
Nord E, Richardson J, Street A, et al. “Who cares about cost? Does economic analysis impose or reflect social values?” Health Policy 1995; 79–94.
Musgrove P. “Public spending on health care: how are different criteria related?” Health Policy 1999; 47: 207–223.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science+Business Media New York
About this chapter
Cite this chapter
Atherly, A., Culler, S.D. (2004). Issues in the Analysis of Cost-Effectiveness in the Diagnosis and Treatment of Coronary Artery Disease in Women. In: Shaw, L.J., Redberg, R.F. (eds) Coronary Disease in Women. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-645-4_26
Download citation
DOI: https://doi.org/10.1007/978-1-59259-645-4_26
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-275-9
Online ISBN: 978-1-59259-645-4
eBook Packages: Springer Book Archive